FDW
NVO

Fourth Dimension Wealth’s Novo Nordisk NVO Stock Holding History

Fourth Dimension Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.6K Buy
96
+30
+45% +$1.29K ﹤0.01% 549
2026
Q1 		$2.43K Sell
66
-17
-20% -$805 ﹤0.01% 520
2025
Q4 		$4.22K Hold
83
– – ﹤0.01% 504
2025
Q3 		$4.61K Sell
83
-397
-83% -$23.2K ﹤0.01% 491
2025
Q2 		$33.1K Sell
480
-100
-17% -$6.8K 0.01% 270
2025
Q1 		$40.3K Buy
580
+100
+21% +$8.26K 0.02% 240
2024
Q4 		$41.3K Buy
+480
New +$51.9K 0.02% 243

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fourth Dimension Wealth's NVO Position: Q2 2026 in Review

Fourth Dimension Wealth increased its Novo Nordisk (NVO) stake by 45% in Q2 2026, buying an estimated $1.29K and bringing the position to 96 shares worth $4.6K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Fourth Dimension Wealth first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $41.3K in Q4 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Fourth Dimension Wealth held 96 shares of Novo Nordisk worth $4.6K as of Q2 2026.
  • Fourth Dimension Wealth bought 30 Novo Nordisk shares in Q2 2026, an estimated $1.29K.
  • Novo Nordisk made up ﹤0.01% of Fourth Dimension Wealth's portfolio in Q2 2026, its #549 holding.
  • Fourth Dimension Wealth first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • Fourth Dimension Wealth's Novo Nordisk position peaked at $41.3K in Q4 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Fourth Dimension Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.